Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9

Biochemical and Biophysical Research Communications

Volumn 376, Issue 4, 2008, Pages 743-747

  Ahn, Jun Seok ^a   Kim, Min kyung ^a   Hahn, Jang hee ^a   Park, Jung Hyeun ^a   Park, Kyeong Han ^a   Cho, Byung Ryul ^b   Park, Seung Bae ^b   Kim, Dae joong ^a  

^a Kangwon National University   (South Korea)

^b Kangwon National University College of Medicine   (South Korea)

Author keywords

AP 1; MMP 9; Tissue transglutaminase; Transcription

Indexed keywords

GELATINASE B; PROTEIN C JUN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN TISSUE TRANSGLUTAMINASE; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL LYSATE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BINDING SITES; CELL LINE; CULTURE MEDIA; DOWN-REGULATION; GTP-BINDING PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 9; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSGLUTAMINASES;

EID: 53449093700     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.048     Document Type: Article

References (31)

1. McCawley L.J., and Matrisian M.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr. Opin. Cell Biol. 13 (2001) 534-540
2. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
3. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
4. Woessner Jr. J.F. Role of matrix proteases in processing enamel proteins. Connect. Tissue Res. 39 (1998) 69-73
5. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., and Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58 (1998) 1048-1051
6. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., and Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92 (1998) 391-400
7. Kai H., Ikeda H., Yasukawa H., Kai M., Seki Y., Kuwahara F., Ueno T., Sugi K., and Imaizumi T. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 32 (1998) 368-372
8. Inokubo Y., Hanada H., Ishizaka H., Fukushi T., Kamada T., and Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am. Heart J. 141 (2001) 211-217
9. Tolentino P.J., Waghray A., Wang K.K., and HayesL R.L. Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats. J. Neurochem. 89 (2004) 1301-1307
10. Tolentino P.J., Waghray A., Wang K.K., and HayesL R.L. Trends Biochem. Sci. 27 (2002) 534-539
11. Molberg O., Mcadam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Noren O., Roepstorff P., Lundin K.E., Sjostrom H., and Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4 (1998) 713-717
12. Novogrodsky A., Quittner S., Rubin A.L., and Stenzel K.H. Transglutaminase activity in human lymphocytes: early activation by phytomitogens. Proc. Natl. Acad. Sci. USA 75 (1978) 1157-1161
13. Sohn J., Kim T.I., Yoon Y.H., Kim J.Y., and Kim S.Y. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J. Clin. Invest. 111 (2003) 121-128
14. Barsigian C., Stern A.M., and Martinez J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators. J. Biol. Chem. 266 (1991) 22501-22509
15. Sane D.C., Moser T.L., Pippen A.M., Parker C.J., Achyuthan K.E., and Greenberg C.S. Vitronectin is a substrate for transglutaminases. Biochem. Biophys. Res. Commun. 157 (1998) 115-120
16. Aeschlimann D., and Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J. Biol. Chem. 266 (1991) 15308-15317
17. Kleman J.P., Aeschlimann D., Paulsson M., and van der Res M. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34 (1995) 13768-13775
18. Fesus L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27 (2002) 534-539
19. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4 (2003) 140-156
20. Janiak A., Zemskov E.A., and Belkin A.M. Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol. Biol. Cell 17 4 (2006) 1606-1619
21. Zhu Y.K., Liu X., Ertl R.F., Kohyama T., Wen F.Q., Wang H., Spurzem J.R., Romberger D.J., and Rennard S.I. Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture. Am. J. Respir. Cell Mol. Biol. 25 (2001) 620-627
22. Mook O.R., Frederiks W.M., and Van Noorden C.J. The role of gelatinases in colorectal cancer progression and metastasis. Biochem. Biophys. Acta 1705 (2004) 69-89
23. Himelstein B.P., Lee E.J., Sato H., Seiki M., and Muschel R.J. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin. Exp. Metastasis 16 (1998) 169-177
24. Lesort M., Attanavanich K., Zhang J., and Johnson G.V. Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem. 273 (1998) 11991-11994
25. Singh U.S., Erickson J.W., and Cerione R.A. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 34 (1995) 15863-15871
26. Slife C.W., Dorsett M.D., Bouquett G.T., Register A., Taylor E., and Conroy S. Subcellular localization of a membrane-associated transglutaminase activity in rat liver. Arch. Biochem. Biophys. 241 (1985) 329-336
27. Kim J.H., Nam K.H., Kwon O.S., Kim I.G., Bustin M., Choy H.E., and Park S.C. Histone cross-linking by transglutaminase. Biochem. Biophys. Res. Commun. 293 (2002) 1453-1457
28. Lee J., Kim Y.S., Choi D.H., Bang M.S., Han T.R., Joh T.H., and Kim S.Y. Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J. Biol. Chem. 279 (2004) 53725-53735
29. Han J.A., and Park S.C. Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol. Cells 10 (2000) 612-618
30. Crowe D.L., and Brown T.N. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1 (1999) 368-372
31. Liu S., Li Y., Zhao H., Chen D., Huang Q., Wang S., Zou W., Zhang Y., Li X., and Huang H. Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats. Mol. Cell. Biochem. 284 1-2 (2006) 9-17